Skip to main content

Elevance Health, Inc.

corporate_fare Company Profile

Elevance Health, Inc.

ELV·NYSE·Finance·CIK 0001156039

Elevance Health is a leading health company focused on enhancing well-being and advancing health outcomes by delivering integrated health solutions. The company supports consumers with medical, pharmacy, and behavioral health services. Elevance Health is one of the largest health insurers in the United States, serving approximately 45.2 million medical members through its affiliated health plans as of December 31, 2025. The company offers a broad spectrum of network-based managed care risk-based plans to Individual, Employer Group, Medicaid, and Medicare markets. Additionally, Elevance Health provides managed care services to fee-based customers, including claims processing, stop loss insurance, care provider network access, medical management, care management, wellness programs, actuarial services, and other administrative services. Revenue is generated through risk-based premiums, administrative fees from self-funded employers, and pharmacy and health service fees through its Carelon businesses. Elevance Health provides services to the federal government through its Federal Health Products & Services business, which administers the Federal Employee Program ® (FEP ® ). The company also offers specialty services to both customers of its subsidiary health plans and unaffiliated health plans, including pharmacy services, stop loss insurance, dental, vision, and supplemental health insurance benefits, as well as integrated health services. Elevance Health is an independent licensee of the Blue Cross and Blue Shield Association.

Elevance Health, Inc. (NYSE:ELV) is a publicly traded company in the Finance sector. Wiseek has independently scored 19 items for ELV at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-05, rated 7/10. Across its 19 most recent items scored 7 or higher, the top rating is 9/10, with 13 rated 8 or above. Recent SEC coverage for ELV spans 10-Q, 8-K, 10-K.

Recent high-impact activity:

  • Elevance Sues Autism-Therapy Provider Over $160 Million in Alleged Fraud
  • Elevance Q3 10-Q: EPS Up 17.9%, but Health Benefits Margin Compresses and 2027 Star Ratings Slip
  • Elevance Beats Q3, Raises FY26 EPS Guidance to at Least $29.00
  • Elevance Beats Q3 by $2.28 a Share, Lifts 2026 EPS Outlook to at Least $29
  • Elevance Health Q2: Membership Slides 1.5%, CMS Risk Adjustment Matter Closed

Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
$199.13B
Net Income
$5.66B
Diluted EPS
$25.21
Op. Cash Flow
$4.29B
Free Cash Flow
$3.17B
Gross Profit
$177.95B
Operating Income
$7.2B
Cash & Equivalents
$9.49B
Total Debt
$31.9B
Debt / Equity
0.73×
Net Margin
2.8%
Shares Outstanding
220.72M sh
Source: 10-K · filed 2026-02-06 · accession 0001156039-26-000013

Short Interest & Short Volume

3.26 days to cover

FINRA reported short interest of 4,544,947 shares in ELV as of the October 30, 2026 settlement, a 11.5% decrease from the prior period — about 3.3 days to cover at its recent average daily volume. On November 20, 2026, 59.9% of ELV volume reported to FINRA trade-reporting facilities was marked short.

Short interest (bi-monthly positions)4,544,947 shares as of October 30, 2026
Change vs prior period▼ 11.5%
Days to cover3.26 at avg daily volume of 1,393,694
Daily short volume (FINRA facilities)59.9% of 515,254 shares on November 20, 2026
5-day average short volume51.8%

Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.

Browse all tickers starting with E →
$394 -0.12% today
52-week range · as of 2026-10-21 $274.84 – $450.69
Market cap
$85.23B
Volume
2M (1.4× avg)
3-mo avg 1.5M
Live data · 2026-11-22 12:39 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed ELV - Latest Insights

ELV
Nov 05, 2026, 1:13 PM EST
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $426.93
Real-time Price: $394.00 info
Change: -$32.93 (-8%) info
Market Cap: $85.23B info
ELV
Oct 21, 2026, 2:14 PM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $441.36
Real-time Price: $394.00 info
Change: -$47.36 (-11%) info
Market Cap: $85.23B info
ELV
Oct 21, 2026, 6:01 AM EDT
Filing Type: 8-K
Importance Score:
8
Updated Oct 21, 7:15 AM ET — Elevance's Q3 total revenue rose 1.4% to $51.43 billion, topping the $49.22 billion analyst forecast, and shares rose 2.1% to $449.49 prema…
Price at Filing: $450.00
Real-time Price: $394.00 info
Change: -$56.00 (-12%) info
Market Cap: $85.23B info
ELV
Oct 21, 2026, 6:00 AM EDT
Source: Dow Jones Newswires
Importance Score:
9
Price at Filing: $439.00
Real-time Price: $394.00 info
Change: -$45.00 (-10%) info
Market Cap: $85.23B info
ELV
Jul 15, 2026, 11:27 AM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $387.70
Real-time Price: $394.00 info
Change: +$6.30 (+2%) info
Market Cap: $85.23B info
ELV
Jul 15, 2026, 7:37 AM EDT
Source: Dow Jones Newswires
Importance Score:
8
Price at Filing: $395.80
Real-time Price: $394.00 info
Change: -$1.80 (-0.45%) info
Market Cap: $85.23B info
ELV
Jul 15, 2026, 6:51 AM EDT
Source: dpa-AFX
Importance Score:
8
Price at Filing: $385.00
Real-time Price: $394.00 info
Change: +$9.00 (+2%) info
Market Cap: $85.23B info
ELV
Jul 15, 2026, 6:02 AM EDT
Source: Dow Jones Newswires
Importance Score:
8
Price at Filing: $439.60
Real-time Price: $394.00 info
Change: -$45.60 (-10%) info
Market Cap: $85.23B info
ELV
Jul 15, 2026, 6:01 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $427.00
Real-time Price: $394.00 info
Change: -$33.00 (-8%) info
Market Cap: $85.23B info
ELV
Apr 22, 2026, 10:09 AM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $335.53
Real-time Price: $394.00 info
Change: +$58.47 (+17%) info
Market Cap: $85.23B info
ELV
Apr 22, 2026, 6:02 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $342.99
Real-time Price: $394.00 info
Change: +$51.01 (+15%) info
Market Cap: $85.23B info
ELV
Apr 22, 2026, 6:00 AM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $340.00
Real-time Price: $394.00 info
Change: +$54.00 (+16%) info
Market Cap: $85.23B info
ELV
Mar 10, 2026, 6:10 AM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $281.84
Real-time Price: $394.00 info
Change: +$112.16 (+40%) info
Market Cap: $85.23B info
ELV
Mar 10, 2026, 6:02 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $281.84
Real-time Price: $394.00 info
Change: +$112.16 (+40%) info
Market Cap: $85.23B info
ELV
Mar 02, 2026, 6:13 AM EST
Source: Unknown
Importance Score:
8
Price at Filing: $310.05
Real-time Price: $394.00 info
Change: +$83.95 (+27%) info
Market Cap: $85.23B info
ELV
Mar 02, 2026, 6:03 AM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $307.20
Real-time Price: $394.00 info
Change: +$86.80 (+28%) info
Market Cap: $85.23B info
ELV
Feb 26, 2026, 2:59 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $327.36
Real-time Price: $394.00 info
Change: +$66.64 (+20%) info
Market Cap: $85.23B info
ELV
Feb 06, 2026, 2:57 PM EST
Filing Type: 10-K
Importance Score:
7
Price at Filing: $337.42
Real-time Price: $394.00 info
Change: +$56.58 (+17%) info
Market Cap: $85.23B info
ELV
Jan 28, 2026, 6:03 AM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $312.33
Real-time Price: $394.00 info
Change: +$81.67 (+26%) info
Market Cap: $85.23B info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets